Oxandrolone
NDC Package 0185-0271-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Oxandrolone is a medication used to help people regain weight they have lost due to certain medical conditions (such as surgery, chronic infection, trauma, long term use of corticosteroid medication such as hydrocortisone/prednisone). Marketed by Eon Labs, Inc., this product is identified by NDC 0185-0271 and is authorized under FDA application ANDA076897.

Identification & Billing

NDC Package Code
0185-0271-10
Package Description
1000 TABLET in 1 BOTTLE
Product Code
0185-0271
11-Digit Billing Format
00185027110

Clinical Specifications

Proprietary Name
Oxandrolone
Dosage Form
-
Usage Information
This medication is used to help people regain weight they have lost due to certain medical conditions (such as surgery, chronic infection, trauma, long term use of corticosteroid medication such as hydrocortisone/prednisone). It is also used to relieve bone pain due to bone loss (osteoporosis). Oxandrolone belongs to a class of drugs known as anabolic steroids. These drugs are similar to male hormones made by the body.

Regulatory & Marketing

Labeler Name
Eon Labs, Inc.
FDA Application #
ANDA076897
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-01-2006
End Marketing Date
01-11-2013
Listing Expiration
01-11-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0185-0271). Click a package code to view its specific billing and regulatory data.

0185-0271-01
100 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0185-0271-10 identifies a specific commercial package of 1000 tablet in 1 bottle of Oxandrolone, labeled by Eon Labs, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eon Labs, Inc. on December 01, 2006. The current certification is valid through January 11, 2013.

What are the primary indications for this medication?

This medication is used to help people regain weight they have lost due to certain medical conditions (such as surgery, chronic infection, trauma, long term use of corticosteroid medication such as hydrocortisone/prednisone). It is also used to relieve bone pain due to bone loss (osteoporosis). Oxandrolone belongs to a class of drugs known as anabolic steroids. These drugs are similar to male hormones made by the body.

How is this Eon Labs, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00185027110. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0185-0271-10
11-Digit CMS (5-4-2)
00185-0271-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.